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Introduction: Primary nocturnal enuresis (PNE) is a common problem in developmental 
age with an estimated overall prevalence ranging from 1.6% to 15%, and possible persistence 
during adolescence. There is a growing interest in the sleep habits of children affected by PNE, 
which is derived from the contradictory data present in clinical literature. The aim of the present 
study was to evaluate the presence of sleep disturbances in a population of children affected by 
PNE, and to identify whether PNE could be considered as a risk factor for sleep disturbances 
among children.
Materials and methods: A total of 190 PNE children (97 males, 93 females) aged 7–15 years, 
(mean 9.64 ± 1.35 years), and 766 typically developing children matched for age (P = 0.131) and 
gender (P = 0.963) were enrolled. To evaluate the presence of sleep habits and disturbances, all 
of the subjects’ mothers filled out the Sleep Disturbances Scale for Children (SDSC), a question-
naire consisting of six subscales: Disorders in Initiating and Maintaining Sleep (DIMS), Sleep 
Breathing Disorders (SBD), Disorders of Arousal (DA), Sleep–Wake Transition Disorders 
(SWTD), Disorders of Excessive Somnolence (DOES), and Nocturnal Hyperhidrosis (SHY). The 
results were divided into “pathological” and “normal” scores using a cut-off value  (pathological 
score = at least three episodes per week), according to the validation criteria of the test. Then, the 
Chi-square test was used to calculate the statistical difference and a univariate logistic regres-
sion analysis was applied to determine the role of PNE as a risk factor for the development of 
each category of sleep disorders and to calculate the odds ratio (OR).
Results: PNE children show a higher prevalence of all sleep disturbances (41.03% DIMS; 
85.12% SBD; 63.29% DA; 67.53% SWTD; 31.28% DOES; 37.92% SHY; 25.33% SDSC 
total score), and according to OR results (SDSC total score OR = 8.293, 95% confidence 
interval [CI] = 5.079–13.540; DIMS OR = 7.639, 95% CI = 5.192–11.238; SBD OR = 35.633, 
95% CI = 22.717–55.893; DA OR = 13.734, 95% CI = 9.476–19.906; SWTD OR = 14.238, 
95% CI = 9.829–20.625; DOES OR = 5.602, 95% CI = 3.721–8.432; SHY OR = 6.808, 95% 
CI = 4.608–10.059), PNE could be considered as a risk factor for the development of sleep 
disorders.
Conclusion: Among PNE children, sleep could be strongly altered, thus helping to affirm the 
hypothesis that PNE tends to alter sleep architecture, or it could itself be the consequence of an 
abnormal sleep structure. The findings also point to the existence of a potential increase in the 
risk of developing sleep disorders in the presence of PNE.
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Introduction
According to the International Children’s Continence Society criteria,1 nocturnal enure-
sis is defined as the involuntary loss of urine during the night in children over 5 years 
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of age, distinguished in a primary form (primary  nocturnal 
enuresis [PNE]), and in a secondary form (secondary noc-
turnal enuresis).2 Moreover, nocturnal enuresis is divided 
into monosymptomatic nocturnal enuresis with no daytime 
urinary symptoms and nonmonosymptomatic nocturnal 
enuresis, if accompanied by daytime urinary symptoms.1
In general, nocturnal enuresis is a common problem 
during development, with an estimated overall prevalence 
ranging from 1.6% to 15%,3–5 and possible persistence during 
adolescence.6 Bedwetting could be considered more com-
mon in boys, whereas daytime incontinence is prevalent in 
girls.7 The prevalence of nocturnal enuresis tends to decrease 
with age, supporting the traditional idea of maturational 
delay in voiding control, even if other mechanisms may be 
involved.
For years, PNE was interpreted as only resulting from 
unspecified psychological troubles, with no consideration 
for an interesting recent suggestion that PNE shares simi-
larities with another very common symptom that occurs in 
developmental age – migraine without aura.8 In fact, enuresis 
and migraines could be linked by cortical system arousal 
dysfunction, vegetative hyperactivity,9–11 alteration in motor 
and visual coordination,12–14 and sleep disorders.15–17 As such, 
PNE and migraines could be interpreted as forms of familial 
stressors.18,19
From this perspective, PNE could be identified as a sort 
of “periodic syndrome,”20 such as growing pains, motion 
sickness, and others that share many of the same aspects 
as migraine, also considered their effects  on learning 
abilities.21,22 In this light, the treatment should not exclude the 
causal role of both sleep disorders and abnormal behavior,23 
while considering natural approaches such as sleep hygiene,24 
nutraceuticals,25,26 and weight loss.27
On the other hand, there is a growing interest in the sleep 
habits of children affected by PNE, which is derived from 
the contradictory data present in the clinical literature. For 
example, in 2008, Nevéus28 pinpointed the common parental 
report of deep sleep compared to controls, despite the low 
efficiency found in the quality of nighttime sleep as reported 
by children. Moreover, polysomnographic studies conducted 
among individuals affected by PNE are scarce or have been 
performed on small samples, with no conclusive data.
In 2009, Dhondt et al29 reported their polysomnographic 
findings of 29 subjects with refractory enuresis. The authors 
noted an increase in the periodic limb movement percentage 
and a sort of intrinsic hypnic instability, with a high threshold 
in cortical arousability,29 even if this alteration could be not 
identified as the unambiguous pathogenic mechanism.
The aim of the present study was to evaluate the presence 
of sleep disturbances in a population of children affected by 
PNE and to identify whether PNE could be considered as a 
risk factor for sleep disturbances among children.
Materials and methods
The study population consisted of 190 children (97 males, 
93 females) aged 7–15 years (mean 9.64 ± 1.35 years), who 
were consecutively referred from primary care pediatricians 
for PNE. The patients were referred to the following  clinics 
between November 2011 to December 2012: the Center 
of Sleep Disorders for Developmental Age of Child and 
 Adolescent Neuropsychiatry Clinic at the Second University 
of Naples; to the Unit of Child and Adolescent Neuropsy-
chiatry of the Perugia University; to the Azienda Sanitaria 
Locale of Terni; and to the Department of Psychiatry of the 
University of Catanzaro.
The study population was compared with a group com-
posed by 766 typically developing children (390 males, 
376 females) matched for age (P = 0.131) and gender 
(P = 0.963), who were recruited from the Campania, Umbria, 
and Calabria school regions.
All children affected by defined psychiatric illness (ie, schizo-
phrenia, psychosis, attention deficit hyperactivity  disorder), 
mental retardation (intelligence quotient , 75),  neurological 
diseases (ie, epilepsy, neuromuscular disorders, cerebral palsy), 
symptoms of lower urinary tract malfunction and/or infec-
tion, overweight (body mass index [BMI] $85th  percentile), 
or obesity (BMI $ 95th percentile) were excluded.
Data were collected from a pilot group (ten PNE, ten 
control children) and used to perform the sample size 
 calculation. The desired power was set at 0.80 and error 
at 0.05. The sample size was calculated using online software 
(http://www.dssresearch.com/toolkit/sscalc/size_a2.asp). The 
sample size required was found to be 13 subjects for each 
group, but there was the opportunity to recruit more patients 
(956 in total) in order to strengthen our findings.
Sleep habits assessment
To evaluate sleep habits and disturbances, all of the subjects’ 
mothers filled out the Sleep Disturbances Scale for Children 
(SDSC),30 a standardized questionnaire for the assess-
ment of sleep problems during development, consisting of 
26 items grouped into six subscales: Disorders in Initiating 
and Maintaining Sleep (DIMS), Sleep Breathing Disorders 
(SBD), Disorders of Arousal (DA), Sleep–Wake Transition 
Disorders (SWTD), Disorders Of Excessive Somnolence 
(DOES), and Nocturnal Hyperhidrosis (SHY). Both the 
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original or modified versions of this measure are widely used 
in school-aged children.31–35
According to the SDSC validation criteria,30 scores $ 71 
for the SDSC total score, $17 for DIMS, $7 for SBD, $6 for 
DA, $14 for SWTD, $13 for DOES, and $7 for SHY were 
considered as pathological.
The subjects in both groups were recruited from the same 
urban area; participants were Caucasian, and held a middle-
class socioeconomic status.
All parents gave their written informed consent. The study 
was conducted according to the criteria of the Declaration 
of Helsinki.36
Statistical analysis
Mean differences in anthropometric (BMI z-score) and 
clinical characteristics between the PNE individuals and the 
control group were analyzed by t-test.
In order to evaluate the differences among both groups (PNE 
and controls) in terms of the prevalence of the pathological 
items of the SDSC, the results were divided into  “pathological” 
and “normal” scores using a cut-off value  (pathological 
score = at least three episodes per week),  according to the 
validation criteria of the test. Then, the  Chi-square test was 
used to calculate the statistical difference.
The Bonferroni correction was applied, and P-values , 0.01 
were considered to be statistically significant.  Moreover, an 
univariate logistic regression analysis was applied to deter-
mine the role of PNE as a risk factor for the development of 
each category of sleep disorders and to calculate the odds 
ratio (OR). The commercially available Statistica software 
(StatSoft Inc, Tulsa, OK, USA) was used for the statistical 
evaluation.
Results
Two study groups were matched for age (P = 0.131), 
 gender (P = 0.963) and BMI z-score (P = 0.230), as shown 
in Table 1.
Table 2 shows the higher prevalence of pathological 
responses among children affected by PNE across 21 items 
when compared to control subjects, while the remaining 
four items (reluctance to go to sleep, presence of more than 
two awakenings per night, difficulty to go back to sleep, 
sleep apnea) do not differ significantly. Moreover, PNE 
individuals showed higher scores across the SDSC total 
(P , 0.001), DIMS (P , 0.001), SBD (P , 0.001), DA 
(P , 0.001), SWTD (P , 0.001), DOES (P , 0.001), and 
SHY (P , 0.001) scores than controls.
Finally, according to the results of the logistic regres-
sion analysis, PNE could be considered as a risk factor 
for developing sleep disorders according to the following 
results: SDSC total score (OR = 8.293, 95% confidence 
interval [CI] = 5.079–13.540); DIMS (OR = 7.639, 95% 
CI = 5.192–11.238); SBD (OR = 35.633, 95% CI = 22.717–
55.893); DA (OR = 13.734, 95% CI = 9.476–19.906); SWTD 
(OR = 14.238, 95% CI = 9.829–20.625); DOES (OR = 5.602, 
95% CI = 3.721–8.432); and SHY (OR = 6.808, 95% 
CI = 4.608–10.059) (Table 3).
Discussion
In general, the acquisition of urinary continence seems 
to be complex and has probably not yet been completely 
 understood.37 On the other hand, PNE could be considered one 
of the most common and disabling problems during develop-
ment, yet it is still regarded as simple bedwetting, in spite of it 
being identified as a different condition, and presenting with 
various comorbidities such as neuromotor problems,38 atten-
tion difficulties,39 learning disabilities, and the possibility of 
being an epiphenomenon of other symptoms, or the effect of 
particular psychological states.40,41
Paradoxically, sleep disorders might be considered to 
be the most important comorbidity in enuretic children 
given the growing amount of evidence suggesting a 
significant relationship with particular anatomical patterns,42 
obesity,43,44  breathing disorders during sleep,45–47 and various 
comorbidities,48 even if the relationship with other sleep 
disturbances has not yet been investigated. In this light, our 
findings tend to show that there is a higher prevalence of PNE 
children than typically developing children across all classes 
of sleep disturbances.
The pathogenesis of enuresis could be considered based 
on a mutual balance of three basic mechanisms: bladder 
capacity; nocturnal production of urine; and the threshold 
of arousability,49 all of which are elevated in the enuretic 
subject,50 as confirmed by the higher prevalence of DA and 
SWTD in our PNE sample (Table 3).
Table 1 Demographic and anthropometric characteristics of 
children affected by PNE and controls
PNE 
(n = 190)
Normal 
(n = 766)
P
Age 9.64 ± 1.35 10.02 ± 3.44 0.131
Sex ratio (M/F) 97/93 390/376 0.963
z-BMI 0.63 ± 0.38 0.59 ± 0.42 0.230
Notes: In order to verify the gender matching (M/F), the Chi-square test was 
applied; all other characteristics were evaluated by t-test analysis.
Abbreviations: PNE, primary nocturnal enuresis; n, number; M, male; F, female; 
z-BMI, z-score body mass index.
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Table 2 Different percentages of pathological items on the SDSC scales ($3/week) within the group of enuretic children who 
underwent the PSG study, with a starting population of enuretic children and a control group
 PNE 
(n = 190) 
(%)
Control 
(n = 766) 
(%)
Chi-square values Pa
 1. Sleep less than 8 hours 58.95 16.32 146.100 ,0.001
 2. Sleep latency . 30 minutes 33.16 6.53 101.040 ,0.001
 3. Reluctant to go to bed 34.74 36.95 0.232 NS
  4.  Difficulty getting to sleep at night 40 16.45 49.265 ,0.001
 5. Anxiety when falling asleep 61.58 7.7 290.618 ,0.001
 6. Hypnic jerks 61.05 13.05 197.803 ,0.001
 7. Rhythmic movements while falling asleep 36.84 8.62 97.100 ,0.001
 8. Vivid dream-like scenes while falling asleep 35.79 5.09 141.263 ,0.001
 9. Falling asleep sweating 41.58 10.18 107.057 ,0.001
10. More than two awakenings per night 12.10 12.4 0.000 NS
11.  Difficulty to fall asleep after awakenings 8.42 12.66 2.237 NS
12. Nocturnal hyperkinesis 26.84 21.41 2.275 NS
13.  Sleep breathing difficulties 68.95 12.4 266.527 ,0.001
14. Sleep apnea 6.32 6.01 0.000 NS
15. Snoring 54.74 17.23 113.168 ,0.001
16. Night sweating 64.74 13.19 222.644 ,0.001
17. Sleepwalking 22.11 6.66 39.626 ,0.001
18. Sleep talking 51.58 18.15 89.481 ,0.001
19. Teeth grinding 34.21 6.79 104.046 ,0.001
20. Sleep terrors 25.26 5.09 72.465 ,0.001
21. Nightmares 48.95 12.01 130.731 ,0.001
22.  Difficulty in waking up in the morning 41.05 32.38 4.721 ,0.001
23. Awakes in the morning feeling tired 45.26 27.94 20.426 ,0.001
24. Sleep paralysis 34.21 7.57 94.003 ,0.001
25. Daytime somnolence 27.89 9.4 44.207 ,0.001
26. Sleep attacks 15.79 3.13 43.143 ,0.001
Total SDSC 16.32 2.35 58.224 ,0.001
Notes: The total SDSC scale value was considered pathologic if $71. aBonferroni corrected P-value. P , 0.01 was significant.
Abbreviations: SDSC, Sleep Disturbance Scale for Children; PSG, polysomnography; NS, not significant.
Table 3 The differences in the prevalence of pathological scores on the SDSC test between children affected by PNE and typically 
developing children (normal)
PNE 
(n = 190) 
(%)
Normal 
(n = 766) 
(%)
Chi-square P OR 95% CI
DIMS 
pathological score
41.03 8.29 126.121 ,0.001 7.639 5.192–11.238
SBD 
pathological score
85.12 13.94 379.169 ,0.001 35.633 22.717–55.893
DA 
pathological score
63.29 11.09 241.869 ,0.001 13.734 9.476–19.906
SWTD 
pathological score
67.53 12.63 250.131 ,0.001 14.238 9.829–20.625
DOES 
pathological score
31.28 7.41 77.407 ,0.001 5.602 3.721–8.432
SHY 
pathological score
37.92 8.27 108.078 ,0.001 6.808 4.608–10.059
SDSC TOT 
pathological score
25.33 3.98 89.752 ,0.001 8.293 5.079–13.540
Abbreviations: SDSC, Sleep Disturbance Scale for Children; PNE, primary nocturnal enuresis; n, number; OR, odds ratio; CI, confidence interval; DIMS, Disorders  in 
Initiating and Maintaining Sleep; SBD, Sleep Breathing Disorders; DA, Disorders of Arousal; SWTD, Sleep–Wake Transition Disorders; DOES, Disorders Of Excessive 
Somnolence; SHY, Nocturnal Hyperhidrosis; NS, not significant.
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Bader et al51 showed that the sleep macrostructure of 
children affected by bedwetting could be considered as 
normal, even if characterized by the high presence of auto-
nomic arousals before the voiding episodes, denying in 
this way the impairment in arousability.51 However, more 
recently, another sleep study was conducted on 35 enuretic 
subjects who were compared to 21 healthy controls. This 
study reintroduced the concept of dysregulation in the 
“bladder–brain dialogue,” pinpointing the relationship 
between an overactive bladder and the ability to arouse the 
cortex, reporting differences in the sleep macrostructure of 
enuretic subjects, such as different representations of early 
stages of nonrapid-eye-movement sleep and a high rate of 
awakenings per hour.52
These findings tend to suggest the role of the arousal 
system in PNE pathogenesis; specifically, the small area 
around the locus coeruleus in the upper pons has been con-
firmed as playing a key role in PNE in some reports based 
on the activity of the autonomic nervous system.53,54 From 
this point of view, our results about the higher prevalence 
of all sleep disturbances in an enuretic sample (SDSC total 
score, P # 0.001), particularly in SHY (P # 0.001) and 
respiratory troubles during sleep (SBD, P # 0.001) could 
be interpreted as an epiphenomenon of autonomic nervous 
system activity. Conversely, it has been suggested that 
SRBD (particularly in the case of sleep apnea) may result 
in nocturnal diuresis mediated by atrial natriuretic peptide 
and antidiuretic  hormone.46 In fact, conditions of negative 
intrathoracic pressure as a result of inspiratory effort posed 
against a closed airway may result in the release of atrial 
natriuretic peptide due to cardiac distension caused by the 
negative pressure environment. Consequently, this hormone 
could increase water excretion and inhibit both vasopressin 
and the renin–angiotensin–aldosterone complex, which are 
involved in fluid volume regulation. In this light, the higher 
rate of SRBD in enuretic children when compared to healthy 
controls could be explained, even when considering the exclu-
sion of obese subjects in our study sample.
In addition, there is observational evidence to suggest 
that PNE has been found to occur after psychological stress 
or trauma, and that PNE results in increased psychological 
distress for the child;55–57 this suggests a putative role in the 
pathogenesis of DIMS, which was reported in our sample. 
Finally, Gozmen et al,58 in 2008, reported that children 
affected by enuresis tend to have a worse sleep quality when 
compared to unaffected children.
We should take into account some limitations of this 
study. Our data were derived from parental questionnaires 
and not from polysomnographic data and, therefore, the 
accuracy of our findings in evaluating sleep disturbances is 
limited. We could hypothesize that the parents of enuretic 
children could be used to checking  their children during 
sleep in order to search for wetting episodes and to wake 
them more than parents’ of typical developing children. In 
this way, we may speculate that parents of enuretic children 
may pay more attention to the children’s sleep habits when 
compared to other parents.
In spite of these limitations, our study shows that among 
bedwetters, sleep could be strongly altered, thus affirming 
the hypothesis that PNE tends to alter the sleep architecture 
of affected children, or it could itself be the consequence of 
an abnormal sleep structure. In addition, the findings also 
pointed to the existence of a potential increase in the risk of 
developing sleep disorders in the presence of PNE, suggest-
ing a new way to consider the relationship between sleep and 
enuresis in children.
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